Developed & Manufactured by Biomedica

High quality ELISAs
Developed and manufactured by Biomedica

Product Spotlight
FGF23 ELISA kits
for serum and plasma

Featured Products & Promotions

Latest News
  • Sclerostin a biomarker in renal pediatric bone disease
    Sclerostin a biomarker in renal pediatric bone disease
    26 March, 2024
    The Biomedica SCLEROSTIN ELISA Assay Kit (# BI-20492) was utilized in a recent publication assessing the associations between serum and bone sclerostin levels and biomarkers of bone turnover and bone histomorphometry. Read more: Sclerostin, Osteocytes, and Wnt Signaling in Pediatric Renal Osteodystrophy. Sclerostin (SOST) ELISA  (cat. no. BI-20492) Most referenced Sclerostin ELISA in over 290 citations Low sample [...]
  • Cardiac Safety Biomarkers for preclinical cardiotoxicity testing
    Cardiac Safety Biomarkers for Preclinical Cardiotoxicity Testing
    19 March, 2024
    Biomarkers have a longstanding role as indicators of biological changes. In drug development they serve dual purposes: predicting drug efficacy and identifying potential drug toxicity. Cardiotoxicity in one of the causes why preclinical safety tests fail during drug development. Therefore, monitoring cardiac toxicity with biomarkers is an essential part during drug development. Cardiac Safety Biomarkers [...]
  • Keep your kidneys healthy
    Keep your kidneys healthy
    13 March, 2024
    Kidney disease is estimated to affect more than 800 million people worldwide (1). Taking action for prevention, early diagnosis and treatment can reduce the risk and the burden of kidney disease. Role of the kidneys, kidney disease and risk factors Kidneys are vital organs that regulate fluid balance, blood pressure and produce hormones that stimulate [...]
More News
Events
  • Biomedica @ Osteologie in Salzburg
    19 June, 2023
    Biomedica features FGF23 ELISA - intact and C-terminal - assays Meet us at the OSTEOLOGIE Conference taking place from 22-24 June 2023 in Salzburg, Austria! We will exhibit at booth # 36 introducing our novel biomarker ELISA assays to investigate bone and cancer induced bone diseases (e.g. Periostin, Semaphorin 4D, LRG, and others). Our focus [...]
  • Biomedica @ Osteologie 2020 in Salzburg
    17 February, 2020
    Meet us at the Osteologie 2020, hosted by the Deutsche Gesellschaft für Endokrinologie and the Österreichische Gesellschaft für Knochen- und Mineralstoffwechsel, taking place from 12-14 March 2020 in Salzburg, Austria! We will exhibit together with our partners Fianostics & TAmiRNA at booth #1. Moreover,  we will present out new VEGF-A ELISA at our poster "Novel VEGF-A ELISA [...]
  • Biomedica @ ASN
    7 November, 2019
    Meet us during ASN Kidney Week taking place from November 5-10 2019 in Washington, DC at booth no. 2005 Hosted by the American Society of Nephrology it’s the world’s premier nephrology meeting with more than 13,000 kidney specialists from across the globe. It provides participants with exciting and challenging opportunities to exchange knowledge, learn about [...]
More Events